<SEC-DOCUMENT>0001740053-21-000002-index.html : 20210223
<SEC-HEADER>0001740053-21-000002.hdr.sgml : 20210223
<ACCEPTANCE-DATETIME>20210223162332
ACCESSION NUMBER:		0001740053-21-000002
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210223
DATE AS OF CHANGE:		20210223

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-80035
		FILM NUMBER:		21665825

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 900
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 900
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chicago Capital, LLC
		CENTRAL INDEX KEY:			0001740053
		IRS NUMBER:				823400556
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		135 S LASALLE ST
		STREET 2:		SUITE 3450
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603
		BUSINESS PHONE:		3124292335

	MAIL ADDRESS:	
		STREET 1:		135 S LASALLE ST
		STREET 2:		SUITE 3450
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60603
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>coverletter.txt
<DESCRIPTION>COVER LETTER
<TEXT>
Document 1 - file: coverletter.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>2
<FILENAME>dvax13g12312020.pdf
<DESCRIPTION>DVAX 13G 12.31.2020
<TEXT>
Document 2 - file: dvax13g12312020.pdf

</DOCUMENT>
</SEC-DOCUMENT>